Cannabis Alert: No Pot Stock Has More Upside Than This Company

Green Organic Dutchman Holdings Ltd (TSX:TGOD) stock has some clear problems, but those issues have created a huge buying opportunity.

edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Pot stocks soared in 2018. Many companies doubled or tripled in value.

Last year was a different story, however. Most cannabis stocks fell by at least 50%. More than $10 billion in market value was erased.

What will 2020 bring? Following the bear market of 2019, some pot stocks are primed for a rebound. Valuations are the lowest they’ve ever been thanks to cratering expectations. Industry sales, meanwhile, continue to rise, setting the stage of big profits. All you need to do is take some calculated risks.

Green Organic Dutchman Holdings Ltd (TSX:TGOD) is a perfect example.

Once a multi-billion dollar firm, Green Organic is now valued at just $180 million. Investors and analysts are ditching the stock en masse. Yet sales are ready to surge this year, making the stock one of the cheapest in the industry.

How much upside could there be in TGOD stock, and how much risk do you have to assume to achieve that upside? Let’s find out.

A broken industry

The cannabis industry is confused. It used to be stupidly easy to raise money. Today, several former gems are worried about their cash runway.

Additionally, share prices used to respond directly to production claims. If investors believed you’d be selling a ton of pot over the coming months, your stock would surge. That relationship has vanished.

What’s going on?

The biggest realization the market has come to is that pot companies aren’t special unicorns. At their core, these businesses are mostly farming operations. Would a tomato or beet farm trade at sky-high multiples? Probably not. The allure of legal marijuana papered over many of the industry’s weak points.

As a crop that simply grows out of the ground (or hydroponically), cannabis will increasingly become commoditized. It’s happening already.

In Oregon, for example, the state had more than one million pounds of excess production, causing prices to plummet. As more companies scale massive grow operations, pricing in all markets will continue trending lower.

What will happen?

We’re already in the next phase of cannabis investing. Rather than rapid growth, investors are demanding profitable growth. As pricing continues to decline, companies need to prove that they can differentiate their products and command pricing power through customer loyalty, which means creating brands that consumers love.

The market is in wait-and-see mode, but only differentiated businesses capable of turning a long-term profit will emerge from the current mess.

Here’s the deal

Where does this all leave Green Organic?

As its name suggests, Green Organic has 100% organic production. So far, organic cannabis fetches a 10% to 30% premium versus conventional output. There’s some pricing power right there.

But the company is going further. This quarter, management is launching several value-add products that should start to protect the firm from pricing erosion.

Over the coming months, the company plans on selling organic cannabis-infused teas, oil, infusers, vapes, and pre-rolls. Long-term, it plans on launching beverages, topicals, and other medicines.

Based on 2021 sales estimates, TGOD stock trades at 1.1 times forward revenue. The industry peer group trades at 2.5 times 2021 sales estimates. That’s a huge discount!

As a smaller player, TGOD stock may deserve a lower valuation, but at some point, the gap becomes too large to pass up. With 140% in potential upside, now might be the ideal time.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »